Scottsdale, AZ · Founded 2017 · Privately Held (backing)
Developer of a medical diagnostic platform designed to detect key pathological markers in the peripheral nervous system. CND Life Sciences is based in Scottsdale, AZ and was founded in 2017. Its last reported valuation was $30.5 million in Mar 2023. It has raised $29.3 million across 7 recorded rounds; the latest was a $4.3 million debt round in Jun 2026.
Last reported valuation
$30.5M
Oct 2026
Priced at
—
Total raised
$29.3M
Last round
Debt
Jun 2026
Cap table — not yet on record
CND Life Sciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CND Life Sciences with a free account
·The complete investor list: 14 names
·Watch CND Life Sciences: the Monday email on marks, rounds and moves
Where does CND Life Sciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across CND Life Sciences's 7 recorded funding rounds.
